Atlas Trials

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Clinical trial NCT04254107 · TERMINATED

Trial details

NCT number
NCT04254107
Sponsor
Seagen Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction CarcinomaClassical Hodgkin LymphomaDiffuse Large B-cell LymphomaPeripheral T-cell LymphomaCutaneous MelanomaHead and Neck Squamous Cell CarcinomaBladder CancerOvarian CancerTriple Negative Breast CancerCervical Cancer
Start date
2020-05-29
Primary completion
2023-12-01
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.